Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

Restricted access

Object. The Glioma Outcomes Project represents a contemporary analysis of the management of malignant (Grade III and Grade IV/GBM) gliomas in North America. This observational database was used to evaluate the influence of resection, as opposed to biopsy, on patient outcome as measured by the length of survival. Attempts were made to reduce the impact of selection bias by repeating the data analysis after omitting patients with major negative prognostic factors.

Methods. Outcome data from 788 patients accrued from multiple sites over a 4-year period (1997–2001) were analyzed with the primary outcome measure being length of survival. Of these, 565 patients with recent diagnoses formed the basis of the present analysis. Patients were systematically followed up until death or up to 24 months after enrollment in the study, and survival data were correlated with the histopathological grade and location of the tumor, the extent of surgery, the patient's performance status, and demographic factors.

The median length of survival was 40.9 weeks for patients with recently diagnosed GBMs. The true median length of survival for patients with Grade III gliomas was not reached, although there was a 58% survival rate at 104 weeks. In multivariate analysis, resection rather than biopsy (p < 0.0001), age 60 years or younger (p < 0.0001), and a Karnofsky Performance Scale (KPS) score of 70 or greater (p = 0.0004) were associated with a prolonged survival time for patients with Grade III or IV gliomas. The prognostic value of resection compared with biopsy was maintained (p < 0.0001), even after eliminating patients considered to be “poor risk” (those with age > 60 years, KPS score < 70, or presence of multifocal tumors), who may have been overrepresented in the biopsy group. Survival “tails” at 24 months were 58% for Grade III gliomas and 11% for GBMs.

Conclusions. These data provide Class II evidence to support tumor grade, patient's age, and patient's functional status as prognostic factors for survival in individuals with recently diagnosed malignant gliomas. Resection (compared with biopsy) is also a strong prognostic factor; however, no quantitative attempt was made to assess the true extent of the resection.

Article Information

Address reprint requests to: Edward R. Laws, M.D., Department of Neurological Surgery, University of Virginia Health Sciences Center, PO Box 800212, Charlottesville, Virginia 22908. email: el5g@virginia.edu.This work was presented in part by Dr. Laws as part of the Hunt-Wilson Lectures at the American Association of Neurological Surgeons Annual Meeting, Chicago, Illinois, April 2002.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Graph demonstrating differences in survival times among patients who underwent biopsy or resection for Grade III (non-GBM) gliomas or GBMs. In this and the other figures, probability values refer to differences within the same grade of tumor.

  • View in gallery

    Graph showing a comparison of survival times among patients 60 years of age or younger, who underwent biopsy or resection for Grade III gliomas or GBMs.

  • View in gallery

    Graph showing a comparison of survival times among patients 60 years of age or younger, who underwent biopsy or resection for unifocal Grade III gliomas or GBMs.

  • View in gallery

    Graph showing a comparison of survival times among patients 60 years of age or younger who had KPS scores of 70 or higher and underwent biopsy or resection for unifocal Grade III gliomas or GBMs.

References

  • 1.

    Ammirati MVick NLiao YLet al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:2012061987Ammirati M Vick N Liao YL et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201–206 1987

    • Search Google Scholar
    • Export Citation
  • 2.

    Blanshard HJChung FManninen PHet al: Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg 92:89942001Blanshard HJ Chung F Manninen PH et al: Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg 92:89–94 2001

    • Search Google Scholar
    • Export Citation
  • 3.

    Bohinski RJKokkino AKWarnick REet al: Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection. Neurosurgery 48:7317442001Bohinski RJ Kokkino AK Warnick RE et al: Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection. Neurosurgery 48:731–744 2001

    • Search Google Scholar
    • Export Citation
  • 4.

    Brell MIbanez JCaral Let al: Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir 142:7397502000Brell M Ibanez J Caral L et al: Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir 142:739–750 2000

    • Search Google Scholar
    • Export Citation
  • 5.

    Burger PCGreen SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59:161716251987Burger PC Green SB: Patient age histologic features and length of survival in patients with glioblastoma multiforme. Cancer 59:1617–1625 1987

    • Search Google Scholar
    • Export Citation
  • 6.

    Cabantog AMBernstein M: Complications of first craniotomy for intra-axial brain tumour. Can J Neurol Sci 21:2132181994Cabantog AM Bernstein M: Complications of first craniotomy for intra-axial brain tumour. Can J Neurol Sci 21:213–218 1994

    • Search Google Scholar
    • Export Citation
  • 7.

    Cairncross JGPexman JHRathbone MPet al: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17:5705721985Cairncross JG Pexman JH Rathbone MP et al: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17:570–572 1985

    • Search Google Scholar
    • Export Citation
  • 8.

    Ciric IAmmirati MVick Net al: Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21:21261987Ciric I Ammirati M Vick N et al: Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21:21–26 1987

    • Search Google Scholar
    • Export Citation
  • 9.

    Coons SWJohnson PCScheithauer BWet al: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:138113931997Coons SW Johnson PC Scheithauer BW et al: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381–1393 1997

    • Search Google Scholar
    • Export Citation
  • 10.

    Curran WJ JrScott CBHorton Jet al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12:2192271992Curran WJ Jr Scott CB Horton J et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12:219–227 1992

    • Search Google Scholar
    • Export Citation
  • 11.

    Curran WJ JrScott CBHorton Jet al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:7047101993Curran WJ Jr Scott CB Horton J et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704–710 1993

    • Search Google Scholar
    • Export Citation
  • 12.

    Davis FGKupelian VFreels Set al: Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neurooncol 3:1521582001Davis FG Kupelian V Freels S et al: Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neurooncol 3:152–158 2001

    • Search Google Scholar
    • Export Citation
  • 13.

    Devaux BCO'Fallon JRKelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78:7677751993Devaux BC O'Fallon JR Kelly PJ: Resection biopsy and survival in malignant glial neoplasms. A retrospective study of clinical parameters therapy and outcome. J Neurosurg 78:767–775 1993

    • Search Google Scholar
    • Export Citation
  • 14.

    Fadul CWood JThaler Het al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38:137413791988Fadul C Wood J Thaler H et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38:1374–1379 1988

    • Search Google Scholar
    • Export Citation
  • 15.

    Gehan EAWalker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46:1891951977Gehan EA Walker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46:189–195 1977

    • Search Google Scholar
    • Export Citation
  • 16.

    Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:2272311999Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227–231 1999

    • Search Google Scholar
    • Export Citation
  • 17.

    Jackson RJFuller GNAbi-Said Det al: Limitations of stereotactic biopsy in the initial management of gliomas. Neurooncol 3:1932002001Jackson RJ Fuller GN Abi-Said D et al: Limitations of stereotactic biopsy in the initial management of gliomas. Neurooncol 3:193–200 2001

    • Search Google Scholar
    • Export Citation
  • 18.

    Kiwit JCFloeth FWBock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57:76881996Kiwit JC Floeth FW Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57:76–88 1996

    • Search Google Scholar
    • Export Citation
  • 19.

    Kleihues PBurger PCScheithauer BW: Histological Typing of Tumours of the Central Nervous System. Berlin: Springer-Verlag1993Kleihues P Burger PC Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. Berlin: Springer-Verlag 1993

    • Search Google Scholar
    • Export Citation
  • 20.

    Kreth FWWarnke PCScheremet Ret al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:7627661993Kreth FW Warnke PC Scheremet R et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766 1993

    • Search Google Scholar
    • Export Citation
  • 21.

    Lacroix MAbi-Said DFourney DRet al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:1901982001Lacroix M Abi-Said D Fourney DR et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis extent of resection and survival. J Neurosurg 95:190–198 2001

    • Search Google Scholar
    • Export Citation
  • 22.

    Meyer FBBates LMGoerss SJet al: Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76:6776872001Meyer FB Bates LM Goerss SJ et al: Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76:677–687 2001

    • Search Google Scholar
    • Export Citation
  • 23.

    Mohr SLeikauf GDKeith Get al: Microarrays as cancer keys: an array of possibilities. J Clin Oncol 20:316531752002Mohr S Leikauf GD Keith G et al: Microarrays as cancer keys: an array of possibilities. J Clin Oncol 20:3165–3175 2002

    • Search Google Scholar
    • Export Citation
  • 24.

    Nitta TSato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75:272727311995Nitta T Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75:2727–2731 1995

    • Search Google Scholar
    • Export Citation
  • 25.

    Quigley MRMaroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29:3853891991Quigley MR Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29:385–389 1991

    • Search Google Scholar
    • Export Citation
  • 26.

    Rostomily RCBerger MSOjemann GAet al: Postoperative deficits and functional recovery following removal of tumors involving the dominant hemisphere supplementary motor area. J Neurosurg 75:62681991Rostomily RC Berger MS Ojemann GA et al: Postoperative deficits and functional recovery following removal of tumors involving the dominant hemisphere supplementary motor area. J Neurosurg 75:62–68 1991

    • Search Google Scholar
    • Export Citation
  • 27.

    Sawaya R: Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42:3033051999Sawaya R: Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42:303–305 1999

    • Search Google Scholar
    • Export Citation
  • 28.

    Sawaya RHammoud MSchoppa Det al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:104410561998Sawaya R Hammoud M Schoppa D et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056 1998

    • Search Google Scholar
    • Export Citation
  • 29.

    Schulder MLiang DCarmel PW: Cranial surgery navigation aided by a compact intraoperative magnetic resonance imager. J Neurosurg 94:9369452001Schulder M Liang D Carmel PW: Cranial surgery navigation aided by a compact intraoperative magnetic resonance imager. J Neurosurg 94:936–945 2001

    • Search Google Scholar
    • Export Citation
  • 30.

    Taylor WAThomas NWWellings JAet al: Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care. J Neurosurg 82:48501995Taylor WA Thomas NW Wellings JA et al: Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care. J Neurosurg 82:48–50 1995

    • Search Google Scholar
    • Export Citation
  • 31.

    Vives KPPiepmeier JM: Complications and expected outcome of glioma surgery. J Neurooncol 42:2893021999Vives KP Piepmeier JM: Complications and expected outcome of glioma surgery. J Neurooncol 42:289–302 1999

    • Search Google Scholar
    • Export Citation
  • 32.

    Winger MJMacdonald DRCairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:4874931989Winger MJ Macdonald DR Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487–493 1989

    • Search Google Scholar
    • Export Citation

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 518 518 41
Full Text Views 401 308 6
PDF Downloads 168 140 9
EPUB Downloads 0 0 0

PubMed

Google Scholar